GOSS Overview
Upcoming Projects (GOSS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (GOSS)
-
Analyzing the PAH treatment landscape and the potential of KER-012 from Keros Therapeutics and Seralutinib (GB002) from Gossamer Bio
Tickers: GOSS, KROS
Executed On: Feb 28, 2024 at 04:00 PM EST -
Discussing the open label extension results of seralutinib from Gossamer Bio in treating Pulmonary Arterial Hypertension (PAH)
Ticker: GOSS
Executed On: Aug 21, 2023 at 02:15 PM EDT
Expired Projects (GOSS)
Upcoming & Overdue Catalysts (GOSS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (GOSS)
-
Gossamer Bio (GOSS) Announces Presentation of GB004 Phase 1b Clinical Data at United European Gastroenterology Virtual Week 2020
Ticker: GOSS
Occurred on: Oct 12, 2020 -
Novartis (NVS) stops development of fevipiprant LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
Tickers: NVS, GOSS
Occurred on: Dec 16, 2019
Strategic Initiatives (GOSS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
